Clinical Trial: A Clinical Trial to Evaluate the Safety and Tolerability of SYS6077 Injection in Participants With Advanced Malignant Tumor

U.S., Oct. 15 -- ClinicalTrials.gov registry received information related to the study (NCT07873359) titled 'A Clinical Trial to Evaluate the Safety and Tolerability of SYS6077 Injection in Participants With Advanced Malignant Tumor' on Sept. 30.

Brief Summary: This trial is a multi-center, phase I clinical study to evaluate the safety/tolerability, immunogenicity, pharmacokinetic characteristics and preliminary anti-tumor activity of different doses of SYS6077 in patients with malignant tumors.

Study Start Date: Nov. 22

Study Type: INTERVENTIONAL

Condition: Advanced Solid Tumors

Intervention: BIOLOGICAL: SYS6077

Dose 1 of SYS6077

BIOLOGICAL: SYS6077

Dose 2 of SYS6077

BIOLOGICAL: SYS6077

Dose 3 of SYS6077

Recruitment Status: NO...